Home / Health / Love Island Star's Health Linked to 70s Drug
Love Island Star's Health Linked to 70s Drug
10 Mar
Summary
- Former Love Island contestant links his health issues to a 1970s pregnancy drug.
- The drug, DES, is linked to infertility, reproductive issues, and cancer.
- Family advocates for a public inquiry and compensation for DES-affected individuals.

Maxwell Samuda, a former contestant on Love Island, has spoken out about his reproductive health concerns, which he attributes to diethylstilbestrol (DES). His grandmother took the drug in the 1970s to prevent miscarriage, and both his mother and he have since experienced significant health issues. DES, a synthetic estrogen prescribed from the 1940s to 1970s, was given to an estimated 300,000 women. It has been linked to infertility, reproductive abnormalities, and increased cancer risks, including breast, pancreatic, and cervical cancers. The drug was associated with a specific cervical and vaginal cancer in 1971, though its prescription continued in Europe until the late 1970s. Mrs. Maureen Day, Maxwell's grandmother, was diagnosed with breast cancer four years ago after taking DES. Maxwell himself required surgery as a baby for undescended testes and has since experienced other reproductive health issues. His mother, Natalie Samuda, has undergone multiple surgeries and suffers from autoimmune conditions. The family is actively supporting DES Justice UK's campaign for a public inquiry and a compensation scheme for those affected by the drug's generational harms. Campaigners met with the Health Secretary to advance their cause, highlighting that while compensation exists in other countries, the UK lacks a similar provision. The Department of Health and Social Care has alerted NHS clinicians to the impacts of DES and is reviewing support and guidance for those exposed.




